Moscow city government announces record tender for current year

9 August 2018
russia_roubles_rubles_money_big

The government of Russia’s capital Moscow has announced a record tender for the current year, which involves the establishment of production and further supplies of drugs on the total sum of 22.6 billion roubles ($342 million) by 2028, reports The Pharma Letter’s local correspondent.

Under the terms of the tender, the winner will have to establish the production of at least 31 drugs from the approved list by investing at least 3 billion roubles in their production. Deliveries need to have been completed by2028.

In the meantime, the conditions of the tender have already been criticized by some leading Russian drugmakers.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical